Effectiveness of photodynamic therapy in the treatment of Lichen sclerosus: Cell changes in immunohistochemistry

Neuroendocrinology Letters

Volumn 30, Issue 4, 2009, Pages 547-551

  Olejek, Anita ^a   Kozak Darmas, Iwona ^a   Kellas Sleczka, Sylwia ^a,b   Steplewska, Katarzyna ^a   Biniszkiewicz, Tomasz ^a   Birkner, Beata ^a   Jarek, Anna ^a   Nowak, Leszek ^a   Stencel Gabriel, Krystyna ^a   Sieron, Aleksander ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

Immunohistochemical staining; Lichen sclerosus; Photodynamic therapy; Vulva

Indexed keywords

AMINOLEVULINIC ACID; CD3 ANTIGEN; CD34 ANTIGEN; HERMES ANTIGEN; KI 67 ANTIGEN; PHOTOSENSITIZING AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LICHEN SCLEROSUS ET ATROPHICUS; LYMPHOCYTIC INFILTRATION; MULTIPLE CYCLE TREATMENT; PHOTODYNAMIC THERAPY; PROTEIN EXPRESSION; PRURITUS; PUNCH BIOPSY; T LYMPHOCYTE;

EID: 76049117542     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Bamberger ES, Perrett CW (2002). Angiogenesis in benign, pre-malignant and malignant vulvar lesions. Anitcancer Res; 11: 3853-3865.
2. Campbell SM, Gould DJ, Salter L, Clifford T, Curnow A (2004). Photodynamic therapy using meta-tetrahydroxyphenylchlorin (Foscan) for the treatment of vulvar intraepithelial neoplasia. Br J Dermatol 151: 1076-1080.
3. Carlson JA, Grabowski R, Chichester P et al (2002). Comparative immunophenotypic study of lichen sclerosus. Am J Dermatopathol 24: 97-107.
4. Chil A, Kopczyński J, Starzewski J et al (2005). Immunohistochemical assessment of lympocytic infiltrate and selected markers of activation of the immune system (Fas, HLA-DR) In lichen sclerosus associated with vulvar cancer. Gynecol Oncol 3: 160-169.
5. Farell AM, Marren P, Dean D, Wojnarowska F (1999). Lichen sclerosus: evidence that immunological changes occur AT All levels of the skin. Br J Dermatol 140: 1087-1092.
6. Fehr MK, Hornung R, Schwarz VA, Simeon R, Haller U, Wyss P (2001). Photodynamic therapy of vulvar intraepithelialneoplasia III using topically applied 5-aminolevulinic acid. Gynecol Oncol; 80: 62-66.
7. Gross T, Wagner A, Ugurel S, Tilgen W, Reinhold U (2001). Identification of TIA-1+ and granzyme B+ cytotoxic T cells in lichen sclerosus et atrophicus. Clin Lab Invest 202: 198-202.
8. Hillemanns P, Untch M, Dannecker Ch et al (2000). Photodynamic therapy of vulvar neoplasia using 5-aminolevulinic acid. Int J Cancer 85: 649-653.
9. Hillemanns P, Untch M, Procombining double acute accentve F et al (1999). Photodynamic therapy of vulvar lichen sclerosus with 5-aminolevulinic acid. Obst Gynecol 93: 71-74.
10. Kaya G, Augsburger E, Stamenkovic I, Saurat JH (2000). Decrease in epidermal CD44 expression as a potential mechanism for abnormal hyaluronate accumulation in superficial dermis in lichen sclerosus and atrophicus. J Invest Dermatol 115: 1054-1058.
11. Kurwa HA, Barlow RJ, Neill S (2000). Single-episode photodynamic therapy and vulvar intraepithelial neoplasia type III resistant to conventional therapy. Br J Dermatol 143: 1040-1042.
12. Li Ch, Bian D, Chen W, Zhao Ch, Yin N, Wang Z (2004). Focused ultrasound therapy of vulvar dystrifies: a feasibility study. Am Obst Gynecol 104: 915-921.
13. Lukowsky AJ, Muche M, Sterry W, Audring H (2000). Detection of expanded T cell clones in skin biopsy samples of patients with lichen sclerosus et atrophicus by T cell receptor-γ polymerase chain reaction assay. J Invest Dermatol 115: 254-259.
14. Meffert JJ, Davis BM, Grimwood RE (1995). Lichen sclerosus. Am J Acad Dermatol 32: 393-416.
15. Olejek A, Rembielak-Stawecka B, Kozak-Darmas I, Biniszkiewicz T, Sieroń A (2004). Photodynamic diagnosis and therapy in gynecology - current knowledge. Ginekol Pol; 75: 228-234.
16. Rasspollini MR, Asirelli G, Taddei GL (2007). The role of angiogenesis and COX-2 expression in the evolution of vulvar lichen sclerosus to squamous cell carcinoma of the vulva. Gynecol Oncol 106: 567-571.
17. Rolfe KJH, Crtow JC, Reid WN, Benjamin E, MacLean AB, Perrett CW (2002). The effect of topical corticosteriods on Ki67 and p53 expression In vulvar lichen sclerosus. Br J Dermatol 147: 503-508.
18. Rolfe KJ, Eva LJ, MacLean AB, Crow JC, Perrett CW, Reid WM (2001). Cell cycle proteins as molecular markers of malignant change in vulvar lichen sclerosus. Int J Gynecol Cancer 11: 113-118.
19. Saravanamuthu J, Reid WM, George DS et al (2003). The role of angiogenesis in vulvar cancer, vulvar intraepithelial neoplasia and vulvar lichen sclerosus as determined by microvessel density analaysis. Gynecol Oncol 89: 251-258.
20. Tchórzewski H, Rotsztejn H, Banasik M, Lewkowicz P, Głowacka E (2005). The involvment of immunoregulatory T cells in the pathogenesis of lichen sclerosus. Med Sci Monit 11: 39-43.
21. Zaki I, Dalziel KL, Solomonsz FA, Stevens A (1996). The under-reporting of skin disease in association with squamous cell carcinoma of the vulva. Clin Exp Dermatol 21: 334-337.